- For Patients
- Introduction to the Marshall Protocol
- Length of the MP
- Immunopathology
- Managing immunopathology
- Food and drink
- Light restriction
- Vitamin D metabolite calculator - get feedback on vitamin D results
- Therapeutic probe - best method for determining MP suitability
- Starting the Marshall Protocol
- Resources for patients
- Marshall Protocol summary
- Palliative vs. curative treatments
- Patient interviews on Bacteriality
- Non-MP treatments
- Glossary
- The Protocol
- Marshall Protocol summary
- Publications and presentations
- Science behind immunopathology
- Science behind olmesartan (Benicar)
- Safety of olmesartan
- Resources for physicians
- Vitamin D metabolite calculator - get feedback on vitamin D results
- Therapeutic probe - best method for determining MP suitability
- Physicians' concerns about the MP
- Notice for emergency medical personnel
- The Pathogenesis
- Publications and presentations
- Science behind Marshall Pathogenesis
- Microbes in the human body
- Successive infection and variability in disease
- Autoimmune theory of disease
- Science behind vitamin D
- Metabolism of vitamin D and the VDR
- Th1 Spectrum Disorder - how chronic inflammatory diseases are related
- Transmission of bacteria and onset of chronic disease
- Evolutionary perspective on disease
- Incidence and prevalence of disease
- Evidence that chronic disease is caused by pathogens
- Diseases
- Foundation
- Related Sites
Differences
This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revisionNext revision | Previous revisionNext revisionBoth sides next revision | ||
| home:diseases:cfs [01.06.2019] – [Chronic fatigue syndrome (myalgic encephalomyelitis)] sallieq | home:diseases:cfs [02.28.2019] – [Statistics] sallieq | ||
|---|---|---|---|
| Line 60: | Line 60: | ||
| The absence of clear laboratory markers affects not only how CFS is diagnosed, but whether or not it is viewed as fundamentally psychological illness, and how it is treated. | The absence of clear laboratory markers affects not only how CFS is diagnosed, but whether or not it is viewed as fundamentally psychological illness, and how it is treated. | ||
| + | |||
| + | ==== Recent research ==== | ||
| + | |||
| + | This work contributes key elements to the development of ME/CFS diagnostics, | ||
| + | |||
| + | Disturbances in fatty acid and lipid metabolism | ||
| + | | ||
| + | Altered composition of the gut microbiome | ||
| + | |||
| =====Symptoms===== | =====Symptoms===== | ||
| Line 220: | Line 229: | ||
| //**Trevor Marshall, PhD**//</ | //**Trevor Marshall, PhD**//</ | ||
| - | ===== Statistics | + | ===== Data ===== |
| - | // | + | |
| - | from DJ in California// | + | //from DJ in California// |
| During the summer of 2013 I looked at 2,000 records of people using the Marshall Protocol. | During the summer of 2013 I looked at 2,000 records of people using the Marshall Protocol. | ||
| Line 419: | Line 428: | ||
| [[https:// | [[https:// | ||
| + | |||
| + | Chronic fatigue syndrome patients have alterations in their oral microbiome composition and function. | ||
| + | |||
| {{tag> | {{tag> | ||
home/diseases/cfs.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.